Follow The Filings

CARE Carter Bankshares

Carter Bankshares earnings company data as of 2:59 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 22 Oct EPS 0.54 — —
Rev — — —

Insider trades

Open-market buys and sales by CARE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CARE insider trades
  • $120K bought by 1 insider
  • $374K sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Catharine L. Midkiff Director
    Sale
    $31K 1,000 shares at $31.25 5.6% of stake
    Traded Sep 11 Filed Sep 11
  2. Bradford N. Langs President, Chief Strategy Ofcr
    Sale
    $86K 2,500 shares at $34.54 7% of stake
    Traded Jul 30 Filed Jul 30
  3. Robert M. Bolton Director
    Sale
    $52K 1,500 shares at $34.60 2.7% of stake
    Traded Jul 30 Filed Jul 30
  4. Bradford N. Langs President, Chief Strategy Ofcr
    Sale
    $146K 5,500 shares at $26.47 17% of stake
    Traded May 12 Filed May 12
  5. Elizabeth L. Walsh Director
    Buy
    $120K 4,575 shares at $26.20 +8.4% to stake
    Traded May 6 Filed May 7
  6. James W. Haskins Director
    Sale
    $26K 1,000 shares at $26.04 1.6% of stake
    Traded May 5 Filed May 6
  7. Robert M. Bolton Director
    Sale
    $33K 1,901 shares at $17.23 15% of stake
    Traded Oct 30, 2025 Filed Nov 3, 2025

Also filed in the last 12 months, not counted as buying or selling: 31 stock grants, 12 share withholdings for taxes, and 5 gifts.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
8-K 8.01
SCHEDULE 13G/A —
8-K 8.01
10-Q
SCHEDULE 13G/A —
8-K 7.01,9.01
8-K 2.02,9.01
8-K 8.01,9.01
8-K 5.02,9.01
8-K 5.07
8-K 7.01
SCHEDULE 13G/A —
10-Q
8-K 8.01
8-K 7.01,9.01
SCHEDULE 13G —
8-K 2.02,9.01
8-K 8.01,9.01
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.